/OM
OM Stock - Outset Medical, Inc.
Healthcare|Medical - DevicesNASDAQ
$3.70+2.49%
+$0.09 (+2.49%) • Dec 19
53
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.39
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+183.8%upside
Target: $10.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.66 – $3.74
TARGET (TP)$10.50
STOP LOSS$3.40
RISK/REWARD1:22.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.02
52W High$25.35
52W Low$3.59
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $113.69M | $130.38M | $115.38M | $102.60M | $49.94M |
| Gross Profit | $38.56M | $29.00M | $17.83M | $7.61M | $-13,037,000 |
| Gross Margin | 33.9% | 22.2% | 15.5% | 7.4% | -26.1% |
| Operating Income | $-113,375,000 | $-169,770,000 | $-161,019,000 | $-130,519,000 | $-117,467,000 |
| Net Income | $-127,976,000 | $-172,797,000 | $-162,956,000 | $-131,935,000 | $-120,698,000 |
| Net Margin | -112.6% | -132.5% | -141.2% | -128.6% | -241.7% |
| EPS | $-2.46 | $-3.48 | $-3.38 | $-2.89 | $-2.83 |
Company Overview
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
4
57%
Hold / Neutral
2
29%
Sell / Underperform
1
14%
Analyst Consensus🟡 Mixed
4 Bullish3 Neutral/Bearish
Price Targets
$9
Average Target
↑ 146.6% Upside
Now
$3
Low
$9
Average
$23
High
Based on 8 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| August 8th 2024 | RBC Capital Mkts | Downgrade | Sector Perform | $3← $6 |
| June 21st 2024 | RBC Capital Mkts | Upgrade | Outperform | $6← $5 |
| April 8th 2024 | BTIG Research | Initiation | Buy | $6 |
| April 5th 2024 | CL King | Upgrade | Buy | $6 |
| January 12th 2024 | RBC Capital Mkts | Downgrade | Sector Perform | $6← $14 |
| October 13th 2023 | BofA Securities | Downgrade | Underperform | $3← $32 |
| August 17th 2023 | CL King | Initiation | Neutral | - |
| November 11th 2022 | RBC Capital Mkts | Initiation | Outperform | $23 |
| July 14th 2022 | Morgan Stanley | Downgrade | Equal Weight | $20← $48 |
Earnings History & Surprises
OMBeat Rate
53%
Last 17 quarters
Avg Surprise
-11.1%
EPS vs Estimate
Beats / Misses
9/8
Last 12 quarters
Latest EPS
$-0.84
Q3 2025
EPS Surprise History
Q4 23
-7.5%
$-10.64vs$-9.90
Q1 24
+3.3%
$-8.85vs$-9.15
Q2 24
-7.5%
$-8.55vs$-7.95
Q3 24
-9.3%
$-7.05vs$-6.45
Q4 24
+7.1%
$-5.85vs$-6.30
Q1 25
+14.0%
$-5.55vs$-6.45
Q2 25
-234.0%
$-3.24vs$-0.97
Q3 25
+52.3%
$-0.84vs$-1.76
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Feb 18, 2026 | $-0.45 | — | — | — |
Q4 2025 | Nov 10, 2025 | $-0.66 | — | — | — |
Q3 2025 | Aug 6, 2025 | $-1.76 | $-0.84 | +52.3% | ✓ BEAT |
Q2 2025 | May 7, 2025 | $-0.97 | $-3.24 | -234.0% | ✗ MISS |
Q1 2025 | Feb 19, 2025 | $-6.45 | $-5.55 | +14.0% | ✓ BEAT |
Q4 2024 | Nov 6, 2024 | $-6.30 | $-5.85 | +7.1% | ✓ BEAT |
Q3 2024 | Aug 7, 2024 | $-6.45 | $-7.05 | -9.3% | ✗ MISS |
Q2 2024 | May 8, 2024 | $-7.95 | $-8.55 | -7.5% | ✗ MISS |
Q1 2024 | Feb 21, 2024 | $-9.15 | $-8.85 | +3.3% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $-9.90 | $-10.64 | -7.5% | ✗ MISS |
Q3 2023 | Aug 2, 2023 | $-10.94 | $-10.34 | +5.5% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $-10.34 | $-10.79 | -4.4% | ✗ MISS |
Q1 2023 | Feb 13, 2023 | $-11.39 | $-10.64 | +6.6% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $-10.64 | $-10.49 | +1.4% | ✓ BEAT |
Q3 2022 | Aug 1, 2022 | $-9.45 | $-11.54 | -22.1% | ✗ MISS |
Q2 2022 | May 4, 2022 | $-9.90 | $-10.04 | -1.4% | ✗ MISS |
Q1 2022 | Feb 16, 2022 | $-10.04 | $-11.54 | -14.9% | ✗ MISS |
Q4 2021 | Nov 3, 2021 | $-9.75 | $-8.85 | +9.2% | ✓ BEAT |
Q3 2021 | Aug 5, 2021 | $-9.90 | $-8.55 | +13.6% | ✓ BEAT |
Latest News
BTIG Reiterates Buy on Outset Medical, Maintains $17 Price Target
📈 PositiveBenzinga•Dec 16, 2025, 10:55 AM
RBC Capital Maintains Sector Perform on Outset Medical, Lowers Price Target to $17
➖ NeutralBenzinga•Nov 11, 2025, 03:27 PM
Outset Medical shares are trading lower after the company reported worse-than-expected Q3 financial results and cut its FY25 sales guidance below estimates.
📉 NegativeBenzinga•Nov 11, 2025, 02:40 PM
BTIG Maintains Buy on Outset Medical, Lowers Price Target to $17
➖ NeutralBenzinga•Nov 11, 2025, 10:46 AM
Outset Medical shares are trading lower after the company reported worse-than-expected Q3 financial results and cut its FY25 sales guidance below estimates.
📉 NegativeBenzinga•Nov 10, 2025, 09:22 PM
Outset Medical Lowers FY2025 Sales Guidance from $122.000M-$126.000M to $115.000M-$120.000M vs $124.140M Est
📉 NegativeBenzinga•Nov 10, 2025, 09:08 PM
Outset Medical Q3 Adj. EPS $(0.69) Misses $(0.66) Estimate, Sales $29.431M Miss $30.880M Estimate
📉 NegativeBenzinga•Nov 10, 2025, 09:08 PM
Outset Medical To Present Findings From Research On Tablo Hemodialysis Treatments Throughout ~750 Sites, 5-Year Results At A Florida Hospital
📈 PositiveBenzinga•Nov 5, 2025, 09:49 PM
RBC Capital Reiterates Sector Perform on Outset Medical, Maintains $22 Price Target
➖ NeutralBenzinga•Aug 19, 2025, 01:43 PM
Frequently Asked Questions about OM
What is OM's current stock price?
Outset Medical, Inc. (OM) is currently trading at $3.70 per share. The stock has moved +2.49% today.
What is the analyst price target for OM?
The average analyst price target for OM is $10.50, based on 1 analyst.
What sector is Outset Medical, Inc. in?
Outset Medical, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is OM's market cap?
Outset Medical, Inc. has a market capitalization of $0.07 billion, making it a small-cap company.
Does OM pay dividends?
No, Outset Medical, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCATX
Perspective Therapeutics, Inc.
$2.75
Mkt Cap: $0.2B
HSDT
Solana Company
$2.98
Mkt Cap: $0.1B
INGN
Inogen, Inc.
$6.71
Mkt Cap: $0.2B
NNOX
Nano-X Imaging Ltd.
$2.99
Mkt Cap: $0.2B
OMI
Owens & Minor, Inc.
$2.84
Mkt Cap: $0.2B
QTRX
Quanterix Corporation
$6.59
Mkt Cap: $0.3B
SI
SHOULDER INNOVATIONS, INC.
$15.32
Mkt Cap: $0.3B
SNWV
SANUWAVE Health, Inc.
$32.25
Mkt Cap: $0.3B
TNYA
Tenaya Therapeutics, Inc.
$0.70
Mkt Cap: $0.1B
VMD
Viemed Healthcare, Inc.
$7.42
Mkt Cap: $0.3B
Explore stocks similar to OM for comparison